Vaxcyte, Inc. (PCVX)
58.52
-0.88
(-1.48%)
USD |
NASDAQ |
Nov 18, 16:00
58.56
+0.04
(+0.08%)
After-Hours: 20:00
Vaxcyte Price : 58.52 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 59.16 | 59.81 | 57.60 | 58.52 | 1.129M |
| Nov 17, 2026 | 61.36 | 62.59 | 59.07 | 59.40 | 1.108M |
| Nov 16, 2026 | 63.37 | 63.79 | 61.46 | 61.61 | 707768.0 |
| Nov 13, 2026 | 64.64 | 64.64 | 62.84 | 63.37 | 623630.0 |
| Nov 12, 2026 | 67.60 | 67.74 | 64.62 | 64.69 | 1.072M |
| Nov 11, 2026 | 67.20 | 68.92 | 66.56 | 68.62 | 1.622M |
| Nov 10, 2026 | 67.00 | 68.18 | 65.85 | 66.36 | 1.269M |
| Nov 09, 2026 | 64.75 | 67.62 | 63.93 | 67.53 | 1.252M |
| Nov 06, 2026 | 61.92 | 65.30 | 61.14 | 63.89 | 1.841M |
| Nov 05, 2026 | 65.88 | 65.88 | 61.84 | 61.92 | 1.834M |
| Nov 04, 2026 | 62.87 | 65.71 | 60.04 | 65.68 | 2.258M |
| Nov 03, 2026 | 61.38 | 61.89 | 60.32 | 60.81 | 2.177M |
| Nov 02, 2026 | 61.88 | 62.87 | 60.15 | 60.62 | 1.320M |
| Oct 30, 2026 | 62.59 | 63.28 | 61.02 | 62.03 | 1.715M |
| Oct 29, 2026 | 61.88 | 63.14 | 61.64 | 62.61 | 2.014M |
| Oct 28, 2026 | 59.92 | 63.94 | 59.58 | 61.46 | 2.213M |
| Oct 27, 2026 | 59.92 | 61.30 | 59.43 | 60.67 | 2.587M |
| Oct 26, 2026 | 60.68 | 61.50 | 59.19 | 59.97 | 1.469M |
| Oct 23, 2026 | 62.35 | 62.77 | 60.27 | 60.43 | 2.062M |
| Oct 22, 2026 | 62.96 | 64.58 | 61.56 | 62.85 | 2.771M |
| Oct 21, 2026 | 66.02 | 67.46 | 63.09 | 63.23 | 3.272M |
| Oct 20, 2026 | 63.80 | 67.01 | 63.68 | 66.23 | 1.957M |
| Oct 19, 2026 | 64.14 | 66.02 | 63.38 | 63.68 | 2.549M |
| Oct 16, 2026 | 65.13 | 65.34 | 62.54 | 63.62 | 3.250M |
| Oct 15, 2026 | 67.72 | 68.33 | 65.00 | 65.27 | 2.448M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 196.79 |
| Vir Biotechnology, Inc. | 9.15 |
| Anavex Life Sciences Corp. | 0.7194 |
| Revolution Medicines, Inc. | 159.82 |
| Foghorn Therapeutics, Inc. | 1.79 |
Price Related Metrics
| PEG Ratio | -0.1099 |
| Price to Book Value | 3.510 |
| Earnings Yield | -13.91% |
| Market Cap | 8.737B |
| PEGY Ratio | -0.1099 |